Question 1

What are the potential benefits of receiving chemotherapy before my surgery?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Neoadjuvant Chemotherapy in Non Small Cell Lung Cancer (NSCLC) Stages IB, IIA, IIB, and IIIA/T3 clinical trial (NCT00273507). Contact the study team or your healthcare provider for specific answers.

Question 2

How do Carboplatin and Paclitaxel work, and what side effects should I expect?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Neoadjuvant Chemotherapy in Non Small Cell Lung Cancer (NSCLC) Stages IB, IIA, IIB, and IIIA/T3 clinical trial (NCT00273507). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the criteria for determining if I can participate in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Neoadjuvant Chemotherapy in Non Small Cell Lung Cancer (NSCLC) Stages IB, IIA, IIB, and IIIA/T3 clinical trial (NCT00273507). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my lung function be assessed to ensure I qualify?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Neoadjuvant Chemotherapy in Non Small Cell Lung Cancer (NSCLC) Stages IB, IIA, IIB, and IIIA/T3 clinical trial (NCT00273507). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Neoadjuvant Chemotherapy in Non Small Cell Lung Cancer (NSCLC) Stages IB, IIA, IIB, and IIIA/T3 clinical trial (NCT00273507). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there other treatment options available for my condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Neoadjuvant Chemotherapy in Non Small Cell Lung Cancer (NSCLC) Stages IB, IIA, IIB, and IIIA/T3 clinical trial (NCT00273507). Contact the study team or your healthcare provider for specific answers.

What this study is about